Centers for Disease Control and Prevention
-
CDC: 8.2% of Adults Not Taking Medications as Prescribed Due To Cost
A recent CDC report found that many Americans are not taking their prescription medications as directed to reduce costs. There are significant differences in Americans doing so based on gender, race and coverage.
-
CDC Sounds Alarm Over Rise in Drug-Resistant Bacteria Shigella: 7 Things to Know
The CDC recently issued an advisory about a bacteria called shigella due to a nationwide increase in infections resulting from drug-resistant strains. The easily transmissible bacteria causes an infection called shigellosis that is uncomfortable and unpleasant but rarely life-threatening — the main symptom is inflammatory diarrhea.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Report: Cancer deaths are down but pancreatic cancer is growing, racial disparities persist
Targeted drugs and immunotherapies are among the advances that contribute to declines in incidence and deaths from non-small cell lung cancer, according to the Annual Report to the Nation on the Status of Cancer. But the trends are on the rise for some other cancers and racial disparities persist, highlighting the need to better understand these differences.
-
U.S. government places $1.74B order for Moderna’s new Covid-19 vaccine boosters
The U.S. government has signed a supply agreement securing 66 million doses of Moderna’s Covid-19 vaccine booster shots, which are designed to address the omicron subvariants driving new cases of infection. The agreement follows a similar supply agreement reached with Pfizer and BioNTech.
-
HHS cites real-world data for Covid-19 boosters; WHO says the science is still out
In announcing plans to offer Covid-19 booster shots, the U.S. Department of Health and Human Services cited declining vaccine efficacy shown by real-world studies. But the World Health Organization said the science is less than clear about booster shots, adding that it’s ethically wrong to give third shots when so many around the world are waiting for their first one.
-
FDA & CDC “pause” J&J Covid-19 vaccine to launch inquiry into rare blood clot cases
Blood clots found in six women given Johnson & Johnson’s Covid-19 vaccine have led federal health officials to recommend a pause on dosing with that shot. A CDC advisory committee on vaccine practices is meeting Wednesday to review the cases, which appear similar to cases observed in Europe with AstraZeneca’s vaccine.
-
Robert Redfield tapped as CDC director, but people haven’t forgotten his controversial background
After former CDC director Brenda Fitzgerald resigned earlier this year, Dr. Robert Redfield was chosen for the position on March 21. But his appointment is marred by reports about his controversial research background.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
CDC directors old and new: What sets Brenda Fitzgerald and Thomas Frieden apart?
Brenda Fitzgerald has been appointed director of the Centers for Disease Control and Prevention. What differentiates her from Thomas Frieden, who previously held the role?
-
Infection-related deaths expose deficiencies in FDA oversight of medical devices
At least 79 cases of infection tied to Sorin heater-cooler units in the U.S. and worldwide have been reported to the FDA since 2010, including 12 deaths. Those numbers are expected to rise.
-
What are the sources behind Google’s health information effort?
Google shared a few more details on its efforts to bring more accurate, reliable medical […]